Intraabdominal sequestration of the lung and elevated serum levels of CA 19-9: a diagnostic pitfall

C. Armbruster, C. Armbruster, S. Kriwanek, H. Feichtinger (Vienna, Austria)

Source: Annual Congress 2004 - Clinical pathobiology of interstitial lung diseases
Session: Clinical pathobiology of interstitial lung diseases
Session type: Thematic Poster Session
Number: 3314
Disease area: Interstitial lung diseases, Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Armbruster, C. Armbruster, S. Kriwanek, H. Feichtinger (Vienna, Austria). Intraabdominal sequestration of the lung and elevated serum levels of CA 19-9: a diagnostic pitfall. Eur Respir J 2004; 24: Suppl. 48, 3314

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The contribution of serum ferritin, iron, iron binding capacity and bronchoalveolar lavage ferritin levels in differential diagnosis of lung cancer from benign pulmonary diseases
Source: Annual Congress 2007 - Biology, diagnosis and rare tumours in thoracic malignancies
Year: 2007


An endo-bronchial lesion with raised CA 19-9 levels
Source: Eur Respir J 2007; 30: Suppl. 51, 563s
Year: 2007

Biodynamic approach to pretreatment level of tumor marker CYFRA 21-1 in differential diagnosis of single pulmonary nodules
Source: Annual Congress 2003 - Early lung cancer diagnosis
Year: 2003


The investigation of diagnostic value of serum reactive protein (CRP) in patients with pleural effusion
Source: Eur Respir J 2006; 28: Suppl. 50, 374s
Year: 2006

Usefulness of serum bird specific antibody levels in patients with interstitial pneumonia
Source: International Congress 2016 – Orphan diseases II
Year: 2016

Serum CA 19-9 in lung allograft recpients
Source: Eur Respir J 2006; 28: Suppl. 50, 778s
Year: 2006

Diagnostic value of CYFRA 21-1, CEA, CA19-9, CA 15-3, and CA 125 assay in pleural effusions: analysis of 116 cases and review of the literature
Source: Eur Respir J 2005; 26: Suppl. 49, 73s
Year: 2005

Evaluation of pleural fluid total protein, albumin, globulin levels and albumin/globulin ratios in the differential diagnosis of pleural effusions
Source: International Congress 2016 – From pleura to bronchi: new insights
Year: 2016


Serum C-reactive protein concentrations in patients with sarcoidosis: can be taken this simple test as an activation marker in sarcoidosis?
Source: Eur Respir J 2004; 24: Suppl. 48, 712s
Year: 2004

Usefulness of serum procalcitonin in lung cancer patients with elevated serum C-reactive protein level
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011

Clinical significance of CEA, NSE, CYFRA 21-1 in serum and pleural fluid for the diagnosis of malignant pleural effusion associated with primary lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 528s
Year: 2004

Role of serum AGE/RAGEs in the differential diagnosis of pulmonary fibrosis
Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias
Year: 2018


Does elevated the pleural fluid creatinine / serum creatinine ratio really mean urinothorax?
Source: Eur Respir J 2004; 24: Suppl. 48, 248s
Year: 2004

The diagnostic value of serum soluble CD 14 and IL-10 levels in newly diagnosed pulmonary tuberculosis patients and the relationship with disease extensity
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013


Increased serum α1-antitrypsin level in COPD patients with predominant lung emphysema
Source: Eur Respir J 2001; 18: Suppl. 33, 248s
Year: 2001

Value of serum procalcitonin levels in the differential diagnosis of pneumonia and pulmonary embolism
Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Year: 2011

Osteopontin levels in sputum supernatant and serum of patients with lung cancer: Does coexistent COPD make the difference?
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013


CEA levels in the serum and induced sputum of lung cancer patients
Source: Eur Respir J 2005; 26: Suppl. 49, 324s
Year: 2005

High serum CA-125 level in active pulmonary tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 415s
Year: 2005

High serum periostin levels and the association with pulmonary tuberculosis
Source: International Congress 2018 – Diagnosis of tuberculosis
Year: 2018